Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Neurogastroenterol Motil. 2016 Apr 8;28(9):1382–1390. doi: 10.1111/nmo.12838

Figure 3.

Figure 3

Baseline and follow-up symptom burden (Panel A: DSI, dominant symptom intensity; Panel B: GSS, global symptom severity) in the study cohort with reflux hypersensitivity (RH), segregated by medical vs. surgical management. Symptom burden significantly improved on follow up (p<0.001). Although baseline symptom burden metrics were similar among medical and surgical groups, there was lesser residual symptom burden among surgical patients compared to medical patients (p=0.09 and p=0.01 for DSI and GSS, respectively).